Nestle's LC1 division has many strengths. Their first is that they have a great CEO, Peter Brabeck. Brabeck emphasizes internal growth, meaning he wants to achieve higher volumes by renovating existing products, and innovating new products. His explanation of renovation is that "to just keep pace in the industry, you need to change at least as fast as consumer expectations."(Hitt, 2005) And his explanation of innovation is "to maintain a leadership position, you also need to leapfrog, to move faster and go beyond what consumers will tell you." Brabeck has led Nestle into a position to better achieve the internal growth targets with his. Another strength that Nestle has is that they are low cost operators. This allows them to not only beat the competition by producing low cost products, but by also edging ahead with low operating costs.
The main weakness of the LC-1 division of Nestle is that they were not as successful as they thought they would be in France. The launch in France was in 1994, but since the late 1980s, Danone had already entered the market with a health-based yogurt. The second weakness is that LC-1 was positioned as too scientific, and consumers didn't quite understand that LC-1 was a food and not a drug.
Nestle also has multiple critical resources. They have a great research and development team. James Gallagher and Andrea Pfeifer were the masterminds behind the research on the La-1 cultures in the LC-1 yogurt. They were also the two that decided on selling LC-1 as a functional food. This enabled Nestle to position the product in a way that differentiated it among the other products in the market. They also have four pillars that Brabeck, Nestle's CEO has identified he believes will help their internal growth worldwide. These are operating excellence, innovation and renovation, product availability, and communication.
One opportunity that Nestle has is that health-based products are becoming more popular in the world, including in the...
Please join StudyMode to read the full document